Search

The House and Senate are working toward FY 2024 appropriations, but not even a negotiated agreement has kept the chambers moving in the same direction. Today, the Senate appropriations committee directed its subcommittees to produce bills that align with the slight reduction in non-defense spending agreed to in the debt ceiling agreement reached earlier this month.

Under Secretary of Commerce for Standards and Technology and National Institute of Standards and Technology (NIST) Director Laurie E. Locascio announced five leaders joining the CHIPS Research and Development Office within CHIPS for America.

Corporate laboratories were hotspots for U.S. innovation for most of the twentieth century. Large firms, such as DuPont or Bell Labs, acted as epicenters for research and development activities, driving investment in frontier technologies underserved by university researchers at the time. By the 1980s, however, many of these powerhouses of industrial research began to cut back on their research programs, paving the way for universities and startups to emerge as new centers of innovation.

U.S. companies spent 18 percent of their research and development dollars outside of the United States in 2013, according to data recently released by the NSF. The $73 billion in foreign R&D is concentrated in the information industry, pharmaceuticals, semiconductors, and automobiles and parts. Those four industries accounted for 52 percent of all foreign R&D performance by U.S.

While the Tax Cuts and Jobs Act of 2017 was passed more than five years ago, many businesses seem to be just discovering the effects of one of its sections this tax season. The law stipulated that, for tax years beginning in 2022, companies could no longer choose to expense their entire “research and experimentation” costs in one year and must instead amortize those cost over five years (with a half year look-back).

A new report compiled by The White House Office of Science and Technology Policy (OSTP) outlines a whole-of-government approach to biotechnology and making it a national priority.

Western democracies are losing the race for scientific and research breakthroughs, and the ability to retain global talent, integral ingredients in developing technologies, according to a recent report from the Australian Strategic Policy Institute (ASPI). In the project funded by the U.S.

The U.S. National Science Foundation announced a new $60 million investment led by NSF's Directorate for Technology, Innovation and Partnerships — the Accelerating Research Translation, or ART, program. The program will build capacity and infrastructure at higher education institutions that are needed to strengthen and scale the translation of basic research outcomes into impactful solutions and practice.

Microbusinesses (businesses with 1-9 domestic employees) spent $7.5 billion in both domestic and foreign R&D expenditures or costs in 2020, of which $6.7 billion was in the U.S. Of this total, $5.6 billion was performed by microbusinesses themselves, according to the National Center for Science and Engineering Statistics (NCSES) and data from the Annual Business Survey (ABS). The $5.6 billion performed by U.S.

A previous Digest article gave a broad overview of the most recent survey of Higher Education Research and Development (HERD) for FY 2021 (the most recent data available), including a breakdown of what field of studies receive the most R&D funding.

New fiscal year (FY) 2021 Higher Education Research & Development (HERD) survey data released by the National Science Foundation (NSF) reveals a $3.4 billion (4%) increase in research and development (R&D) spending by institutions of higher education ($86.5 to $89.9 billion), driven almost entirely by a decades high federal government R&D funding increase of $3 billion.

State government agencies’ expenditures for research and development totaled nearly $2.5 billion in FY 2021, an increase of 1.1% from FY 2020, but far below the year-over-year inflation of 6.4% when measured in February 2022. The findings on state R&D were recently reported by the National Center for Science and Engineering Statistics (NCSES).

A report from ITIF exploring the factors involved in ecosystem strength found that states in Germany generally perform better than states in the U.S., Italy, and Canada in terms of globalization, knowledge economy, and innovation capacity.

Despite COVID-induced setbacks continuing to keep some people out of offices and laboratories, new Business Enterprise Research and Development Survey (BERD) data reveals that domestic research and development (R&D) spending, although slowing, is still on an uptrend.

On the heels of President Biden’s recent announcement of a Biotechnology and Biomanufacturing Initiative to boost the United States bioeconomy, the Congressional Research Service (CRS) has released The Bioeconomy: A Primer, which examines the future of the bioeconomy, explores the United States’ competitiveness in global

Accelerators, incubators and entrepreneurial assistance programs work to ensure their startups understand their product’s market competition, customers, and supply chain. As it turns out, that’s also good advice for small research-based firms trying to move from SBIR proof-of-concept funding to securing the larger Phase II awards.

Each summer, the White House Office of Management and Budget and the Office of Science and Technology Policy distributes a memorandum to all of the executive departments and agencies that are planning to request any research and development funding for a future federal fiscal year that touches on issues or interests that cross multiple agencies. The memo outlines the highest R&D and innovation policy priorities for the administration.

Total R&D in the U.S. grew from $666.9 billion in 2019 to an estimated $708 billion in 2020, according to recent data from the National Science Foundation’s National Center for Science and Engineering Statistics (NCSES) examination of R&D performance in the United States over the past two decades. These findings follow additional trends in the report demonstrating the expanding R&D occurring in the U.S.

Continuing a streak lasting at least 10 years, the federal government was again the top funder of Higher Education R&D (HERD) in 2020. However, new SSTI analysis shows that the federal share of HERD funding has continued to decline nationally and in most states over the 10-year period from 2011 to 2020. This edition of SSTI’s Useful Stats provides an analysis of HERD funders by state in 2020, and an examination of 10-year trends for the period from 2011 to 2020 in HERD funding by source. 

The Illinois Science & Technology Coalition (ISTC) released its 2022 R&D Index earlier this week. The 2022 R&D Index, which is one component of ISTC’s Illinois Innovation Index, assesses Illinois’s capacity for innovation and economic growth amid the COVID-19 pandemic. The last R&D Index released by ISTC was in 2019.

Among the key findings of the report:

Building on previous SSTI analysis showing that Higher Education Research & Development (HERD) expenditures increased across the U.S. despite the onset of the COVID-19 pandemic, this edition of Useful Stats examines the distribution of R&D spending among the various fields of research at the nation’s colleges and universities.

As total Higher Education Research & Development (HERD) expenditures increased nationally and in most states from 2019 to 2020 despite the COVID-19 pandemic and global recession, HERD intensity also increased. HERD intensity is an indicator of the relative importance of R&D spending by colleges and universities to regional economies, and is calculated as HERD expenditures as a percentage of total gross domestic product (GDP).

Despite the Covid-19 pandemic and recession, most states experienced growth in annual Higher Education Research & Development (HERD) expenditures between 2019 and 2020. Given higher education’s role in generating knowledge that catalyzes innovative new technologies developed by high-growth startups, R&D conducted at institutions of higher education is one of the most important metrics for evaluating an area’s innovation economy.

Business research and development (R&D) intensity — private sector R&D expenditures as a percentage of total gross domestic product (GDP) — is an indicator of how interested businesses are in creating new products and processes. This edition of Useful Stats expands upon previous SSTI analyses of business R&D and applies the more standardized measure of “R&D intensity” to provide additional context on the private sector’s activities within states.